Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for NASDAQ stock ARWR Arrowhead Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 65.50 and Closed at: 64.52, which is -0.19% of previous session's close. It moved within a range of 63.46 and 68.44
The session was a Bearish session with an average volume of 24090500, which is 86.53% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 8 days back on short term averages
Support for tomorrow is 61.5 and resistance for tomorrow is 66.48
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 62.51, 60.49 resistance for tomorrow's hourly charts is 67.49, 70.45
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 68.01 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 67.08 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 65.99 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.65 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 34.69 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 67.08 and 200 DMA is at 34.69, while 50 DMA and 100 DMA are at 65.99 and 51.65 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 67.08 and 20 EMA is at 67.24
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 64.52 | 67.08 | 67.24 |
| 05 Thu Feb | 64.64 | 67.11 | 67.53 |
| 04 Wed Feb | 68.06 | 67.16 | 67.83 |
| 03 Tue Feb | 72.14 | 67.3 | 67.81 |
| 02 Mon Feb | 73.00 | 66.88 | 67.35 |
| 30 Fri Jan | 69.33 | 66.62 | 66.76 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 65.99 and 50 EMA is at 62.82
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 64.52 | 65.99 | 62.82 |
| 05 Thu Feb | 64.64 | 65.59 | 62.75 |
| 04 Wed Feb | 68.06 | 65.1 | 62.67 |
| 03 Tue Feb | 72.14 | 64.5 | 62.45 |
| 02 Mon Feb | 73.00 | 63.84 | 62.05 |
| 30 Fri Jan | 69.33 | 63.19 | 61.6 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 51.65 and 100 EMA is at 53.57
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 64.52 | 51.65 | 53.57 |
| 05 Thu Feb | 64.64 | 51.29 | 53.35 |
| 04 Wed Feb | 68.06 | 50.95 | 53.12 |
| 03 Tue Feb | 72.14 | 50.56 | 52.82 |
| 02 Mon Feb | 73.00 | 50.13 | 52.43 |
| 30 Fri Jan | 69.33 | 49.68 | 52.01 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 34.69 and 200 EMA is at 42.28
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 64.52 | 34.69 | 42.28 |
| 05 Thu Feb | 64.64 | 34.42 | 42.06 |
| 04 Wed Feb | 68.06 | 34.15 | 41.83 |
| 03 Tue Feb | 72.14 | 33.87 | 41.56 |
| 02 Mon Feb | 73.00 | 33.57 | 41.25 |
| 30 Fri Jan | 69.33 | 33.26 | 40.93 |
Arrowhead Pharmaceuticals has performed better than Xenon Pharmaceuticals in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Verastem Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Vertex Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 3.08% more returns!
Arrowhead Pharmaceuticals has performed better than Vericel Corporation in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 1.11% more returns!
Sellas Life has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Sellas Life, about 7.23% more returns!
Arrowhead Pharmaceuticals has performed better than Microbot Medical in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Ani Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 7.34% more returns!
Array Biopharma has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Array Biopharma, about 31.97% more returns!
Ascendis Pharma has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ascendis Pharma, about 9.49% more returns!
Arrowhead Pharmaceuticals has performed better than Atricure Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Cellectis S in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Fonar Corporation has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Fonar Corporation, about 0.1% more returns!
Arrowhead Pharmaceuticals has performed better than Hologic Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Healthways Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Healthways Inc, about 7.67% more returns!
Arrowhead Pharmaceuticals has performed better than Insmed Inc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Innoviva Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Innoviva Inc, about 11.39% more returns!
Jazz Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 2.76% more returns!
Arrowhead Pharmaceuticals has performed better than Orthopediatrics Corp in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term but the sell signal is initial and weak.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.26 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


